fda bpc 157 warning peptide Next week, July 23-24, the FDA's Pharmacy Compounding Advisory Committee will review seven peptides being considered for inclusion on the 503A Bulks List. Why does this matter? If these peptides are ultimately FDA takes coser look at

What Does "MIC-B" Stand For

J Maxillofac Oral Surg

Listed as a prohibited substance by WADA (World Anti-Doping Agency)

Metformin is a diabetes treatment

Multistep identification of cell types by clustering After data integration, shared nearest-neighbor (SNN) clustering was performed, and canonical marker genes were used to manually identify cell types

Unfortunately, and ironically with the latest FDA restriction: Only large well-funded companies can afford FDA trials Naturally occurring peptides are hard to patent No patent = no financial incentive No incentive = no approval No approval = no legal compounding Thats the present reality, I hope this regulatory and political standstill will resolved in the coming years